MetLife Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$155K Buy
32,860
+44
+0.1% +$208 ﹤0.01% 2314
2025
Q1
$151K Buy
32,816
+5,210
+19% +$23.9K ﹤0.01% 2337
2024
Q4
$132K Sell
27,606
-5,482
-17% -$26.3K ﹤0.01% 2501
2024
Q3
$155K Hold
33,088
﹤0.01% 2419
2024
Q2
$187K Buy
33,088
+3,324
+11% +$18.8K ﹤0.01% 2292
2024
Q1
$122K Sell
29,764
-837
-3% -$3.44K ﹤0.01% 2446
2023
Q4
$129K Hold
30,601
﹤0.01% 2479
2023
Q3
$132K Hold
30,601
﹤0.01% 2439
2023
Q2
$202K Hold
30,601
﹤0.01% 2272
2023
Q1
$208K Hold
30,601
﹤0.01% 2197
2022
Q4
$226K Hold
30,601
﹤0.01% 2178
2022
Q3
$302K Hold
30,601
﹤0.01% 2018
2022
Q2
$334K Hold
30,601
﹤0.01% 1950
2022
Q1
$346K Buy
30,601
+10,989
+56% +$124K ﹤0.01% 2006
2021
Q4
$308K Buy
19,612
+3,281
+20% +$51.5K ﹤0.01% 1798
2021
Q3
$280K Sell
16,331
-5,053
-24% -$86.6K ﹤0.01% 1865
2021
Q2
$460K Hold
21,384
﹤0.01% 1618
2021
Q1
$321K Sell
21,384
-2,952
-12% -$44.3K ﹤0.01% 1775
2020
Q4
$320K Hold
24,336
﹤0.01% 1728
2020
Q3
$235K Hold
24,336
﹤0.01% 1766
2020
Q2
$278K Hold
24,336
﹤0.01% 1701
2020
Q1
$252K Hold
24,336
﹤0.01% 1572
2019
Q4
$399K Hold
24,336
﹤0.01% 1581
2019
Q3
$323K Hold
24,336
﹤0.01% 1659
2019
Q2
$343K Hold
24,336
﹤0.01% 1713
2019
Q1
$448K Hold
24,336
﹤0.01% 1518
2018
Q4
$636K Hold
24,336
0.01% 1219
2018
Q3
$559K Hold
24,336
0.01% 1466
2018
Q2
$464K Buy
24,336
+4,063
+20% +$77.5K 0.01% 1446
2018
Q1
$342K Hold
20,273
﹤0.01% 1609
2017
Q4
$308K Buy
+20,273
New +$308K ﹤0.01% 1694